骨转移微环境中的代谢重编程
Journal: Basic Medical Theory Research DOI: 10.12238/bmtr.v7i5.16508
Abstract
癌症骨转移是晚期癌症患者的主要并发症。骨转移微环境是一个独特而复杂的龛位,支持骨中癌细胞和正常细胞的生长和进展。代谢串扰在癌症骨转移的发生和进展中起着至关重要的作用。癌细胞通过改变骨细胞的代谢来促进骨转移。因此,了解癌细胞与骨细胞之间的代谢串扰机制对于开发靶向癌症骨转移的新治疗策略至关重要。
Keywords
骨转移；代谢重编程；骨细胞
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Vander Heiden MG,Cantley LC,and Thompson CB. Underst anding the Warburg effect: the metabolic requirements of cell proliferation[J].Science.2009;324:1029-1033.
[2] Finley LWS. What is cancer metabolism?[J].Cell.2023; 186:1670-1688.
[3] Ban J,Fock V,Aryee DNT,et al.Mechanisms,Diagnosis and Treatment of Bone Metastases[J].Cells.2021;10.
[4] Paget S.The distribution of secondary growths in cancer of the breast.1889[J].Cancer Metastasis Rev.1989;8:98-101.
[5] Li B,Lee WC,Song C,et al.Both aerobic glycolysis and mit ochondrial respiration are required for osteoclast differen tiation[J].Faseb j.2020;34:11058-11067.
[6] Jiao JW,Zhan XH, Wang JJ,et al.LOXL2-dependent deacet ylation of aldolase A induces metabolic reprogramming and tumor progression[J].Redox Biol.2022;57:102496.
[7] Di Mauro P,Croset M, Bouazza L,et al.LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer[J].J Bone Oncol.2024;44:100522.
[8] Krzeszinski JY,Schwaid AG,Cheng WY,et al.Lipid Osteocla stokines Regulate Breast Cancer Bone Metastasis[J].Endocrino logy.2017;158:477-489.
[9] Boumelhem BB, Assinder SJ,Bell-Anderson KS,et al.Flow cytometric single cell analysis reveals heterogeneity between adipose depots[J].Adipocyte.2017;6:112-123.
[10] Luo G,He Y,and Yu X.Bone Marrow Adipocyte: An Intim ate Partner With Tumor Cells in Bone Metastasis[J].Front Endo crinol(Lausanne).2018;9:339.
[11] Herroon MK,Rajagurubandara E,Hardaway AL,et al.Bone marrow adipocytes promote tumor growth in bone via FABP4 -dependent mechanisms[J].Oncotarget.2013;4:2108-2123.
[12] Chan GK,Deckelbaum RA,Bolivar I,et al.PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway[J].Endocrinology.2001; 142:4900-4909.
[13] Gregoric G,Gaculenko A,Nagel L,et al.Non-Invasive Cha racterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT[J].Cancers (Basel).2022;14.
[14] Sanchis P,Anselmino N,Lage-Vickers S,et al.Bone Prog enitors Pull the Strings on the Early Metabolic Rewiring Occur ring in Prostate Cancer Cells[J].Cancers (Basel).2022;14.
[15] Gao J,Qin A,Liu D,et al.Endoplasmic reticulum mediat es mitochondrial transfer within the osteocyte dendritic netw ork[J].Sci Adv.2019;5:eaaw7215.
[16] Zhou H,Zhang W,Li H,et al.Osteocyte mitochondria inhi bit tumor development via STING-dependent antitumor immunity [J].Sci Adv.2024;10:eadi4298.
[17] Mehla K,and Singh PK.Metabolic Regulation of Macrop hage Polarization in Cancer[J].Trends Cancer.2019;5:822-834.
[18] Franklin RA,Liao W,Sarkar A,et al.The cellular and mol ecular origin of tumor-associated macrophages[J].Science.2014; 344:921-925.
[19] Zhang X,Li S,Malik I,et al.Reprogramming tumour-asso ciated macrophages to outcompete cancer cells[J]. Nature. 2023;619:616-623.
[20] Renner K,Singer K,Koehl GE, et al. Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment[J]. Front Immunol.2017;8:248.
[21] Baginska J, Viry E, Paggetti J, et al. The critical role of the tumor microenvironment in shaping natural killer cell -mediated anti-tumor immunity[J].Front Immunol.2013;4:490.
[22] Donnelly RP,Loftus RM,Keating SE,et al.mTORC1-depe ndent metabolic reprogramming is a prerequisite for NK cell effector function[J].J Immunol.2014;193:4477-4484.
[23] Chambers AM,Wang J,Lupo KB,et al.Adenosinergic Signa ling Alters Natural Killer Cell Functional Responses[J]. Front Immunol.2018;9:2533.
[2] Finley LWS. What is cancer metabolism?[J].Cell.2023; 186:1670-1688.
[3] Ban J,Fock V,Aryee DNT,et al.Mechanisms,Diagnosis and Treatment of Bone Metastases[J].Cells.2021;10.
[4] Paget S.The distribution of secondary growths in cancer of the breast.1889[J].Cancer Metastasis Rev.1989;8:98-101.
[5] Li B,Lee WC,Song C,et al.Both aerobic glycolysis and mit ochondrial respiration are required for osteoclast differen tiation[J].Faseb j.2020;34:11058-11067.
[6] Jiao JW,Zhan XH, Wang JJ,et al.LOXL2-dependent deacet ylation of aldolase A induces metabolic reprogramming and tumor progression[J].Redox Biol.2022;57:102496.
[7] Di Mauro P,Croset M, Bouazza L,et al.LOX, but not LOXL2, promotes bone metastasis formation and bone destruction in triple-negative breast cancer[J].J Bone Oncol.2024;44:100522.
[8] Krzeszinski JY,Schwaid AG,Cheng WY,et al.Lipid Osteocla stokines Regulate Breast Cancer Bone Metastasis[J].Endocrino logy.2017;158:477-489.
[9] Boumelhem BB, Assinder SJ,Bell-Anderson KS,et al.Flow cytometric single cell analysis reveals heterogeneity between adipose depots[J].Adipocyte.2017;6:112-123.
[10] Luo G,He Y,and Yu X.Bone Marrow Adipocyte: An Intim ate Partner With Tumor Cells in Bone Metastasis[J].Front Endo crinol(Lausanne).2018;9:339.
[11] Herroon MK,Rajagurubandara E,Hardaway AL,et al.Bone marrow adipocytes promote tumor growth in bone via FABP4 -dependent mechanisms[J].Oncotarget.2013;4:2108-2123.
[12] Chan GK,Deckelbaum RA,Bolivar I,et al.PTHrP inhibits adipocyte differentiation by down-regulating PPAR gamma activity via a MAPK-dependent pathway[J].Endocrinology.2001; 142:4900-4909.
[13] Gregoric G,Gaculenko A,Nagel L,et al.Non-Invasive Cha racterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT[J].Cancers (Basel).2022;14.
[14] Sanchis P,Anselmino N,Lage-Vickers S,et al.Bone Prog enitors Pull the Strings on the Early Metabolic Rewiring Occur ring in Prostate Cancer Cells[J].Cancers (Basel).2022;14.
[15] Gao J,Qin A,Liu D,et al.Endoplasmic reticulum mediat es mitochondrial transfer within the osteocyte dendritic netw ork[J].Sci Adv.2019;5:eaaw7215.
[16] Zhou H,Zhang W,Li H,et al.Osteocyte mitochondria inhi bit tumor development via STING-dependent antitumor immunity [J].Sci Adv.2024;10:eadi4298.
[17] Mehla K,and Singh PK.Metabolic Regulation of Macrop hage Polarization in Cancer[J].Trends Cancer.2019;5:822-834.
[18] Franklin RA,Liao W,Sarkar A,et al.The cellular and mol ecular origin of tumor-associated macrophages[J].Science.2014; 344:921-925.
[19] Zhang X,Li S,Malik I,et al.Reprogramming tumour-asso ciated macrophages to outcompete cancer cells[J]. Nature. 2023;619:616-623.
[20] Renner K,Singer K,Koehl GE, et al. Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment[J]. Front Immunol.2017;8:248.
[21] Baginska J, Viry E, Paggetti J, et al. The critical role of the tumor microenvironment in shaping natural killer cell -mediated anti-tumor immunity[J].Front Immunol.2013;4:490.
[22] Donnelly RP,Loftus RM,Keating SE,et al.mTORC1-depe ndent metabolic reprogramming is a prerequisite for NK cell effector function[J].J Immunol.2014;193:4477-4484.
[23] Chambers AM,Wang J,Lupo KB,et al.Adenosinergic Signa ling Alters Natural Killer Cell Functional Responses[J]. Front Immunol.2018;9:2533.
Copyright © 2025 杨长游, 李兆峰, 秦毅
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License